Lixte Average Payables from 2010 to 2025

LIXT Stock  USD 1.30  0.10  7.14%   
Lixte Biotechnology Average Payables yearly trend continues to be comparatively stable with very little volatility. Average Payables will likely drop to about 117.9 K in 2025. Average Payables is the average amount owed to suppliers and creditors over a specific period, reflecting Lixte Biotechnology's payment cycle and credit terms with suppliers. View All Fundamentals
 
Average Payables  
First Reported
2010-12-31
Previous Quarter
184.4 K
Current Value
117.9 K
Quarterly Volatility
53.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lixte Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lixte Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 19.6 K, Other Operating Expenses of 6.1 M or EBITDA of 3.9 K, as well as many indicators such as Price To Sales Ratio of 56.09, Dividend Yield of 2.0E-4 or PTB Ratio of 1.06. Lixte financial statements analysis is a perfect complement when working with Lixte Biotechnology Valuation or Volatility modules.
  
Check out the analysis of Lixte Biotechnology Correlation against competitors.

Latest Lixte Biotechnology's Average Payables Growth Pattern

Below is the plot of the Average Payables of Lixte Biotechnology Holdings over the last few years. It is the average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers. Lixte Biotechnology's Average Payables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lixte Biotechnology's overall financial position and show how it may be relating to other accounts over time.
Average Payables10 Years Trend
Slightly volatile
   Average Payables   
       Timeline  

Lixte Average Payables Regression Statistics

Arithmetic Mean163,954
Geometric Mean153,687
Coefficient Of Variation32.67
Mean Deviation39,233
Median166,920
Standard Deviation53,571
Sample Variance2.9B
Range200.9K
R-Value0.55
Mean Square Error2.2B
R-Squared0.30
Significance0.03
Slope6,147
Total Sum of Squares43B

Lixte Average Payables History

2025117.9 K
2024184.4 K
2022204.9 K
2021208.1 K
2019166.9 K
2018253.6 K
2017235.8 K

About Lixte Biotechnology Financial Statements

Lixte Biotechnology shareholders use historical fundamental indicators, such as Average Payables, to determine how well the company is positioned to perform in the future. Although Lixte Biotechnology investors may analyze each financial statement separately, they are all interrelated. The changes in Lixte Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lixte Biotechnology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Average Payables184.4 K117.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Lixte Stock Analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.